Marshall Wace, LLP Da32 Life Science Tech Acquisition Corp. Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$9.94 - $10.2 $5.73 Million - $5.88 Million
-576,422 Reduced 64.27%
320,517 $3.24 Million
Q1 2022

May 16, 2022
BUY
$9.59 - $9.81 $4.72 Million - $4.83 Million
492,500 Added 121.77%
896,939 $8.75 Million
Q4 2021

Feb 14, 2022
BUY
$9.68 - $9.96 $42,969 - $44,212
4,439 Added 1.11%
404,439 $3.97 Million
Q3 2021

Nov 15, 2021
BUY
$9.76 - $10.26 $3.9 Million - $4.1 Million
400,000 New
400,000 $3.93 Million

About DA32 Life Science Tech Acquisition Corp.

DALS Quotes by TradingView
  • Ticker DALS
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,650,000
  • Description
  • DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...
More about DALS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email